Cargando…
Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
The dynamic evolution of therapeutic options including the use of vitamin K antagonists (VKA), non-vitamin K oral anticoagulants (NOAC), more potent antiplatelet drugs as well as new generation drug-eluting stents could lead to the view that the current recommendations on the management of patients...
Autores principales: | Zalewski, Jarosław, Undas, Anetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133316/ https://www.ncbi.nlm.nih.gov/pubmed/27980542 http://dx.doi.org/10.5114/aic.2016.63626 |
Ejemplares similares
-
Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention
por: Agarwal, Nayan, et al.
Publicado: (2018) -
Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation
por: Undas, Anetta
Publicado: (2020) -
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020) -
Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
por: Undas, Anetta
Publicado: (2016) -
Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)